![Jan Orwar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan Orwar
Directeur/Membre du Conseil chez
FLUICELL AB
Profil
Jan Owe Owesson Orwar was the founder of Cellectricon AB, founded in 2000, where the title held was Director & Chief Scientific Officer.
Dr. Orwar is the founder of Nanoxis AB, founded in 2002, where the title held was Director & Chief Scientific Advisor from 2002 to 2014.
Dr. Orwar is also the founder of Oblique Therapeutics AB. Dr. Orwar is currently Director-Bioeletronics & Bio-Computing Program at Chalmers University of Technology since 2011.
Dr. Orwar is currently Director at Fluicell AB since 2015.
Dr. Orwar is currently Senior Group Leader at Karolinska Institutet.
Former positions include President-Research & Development at Piramal Enterprises Ltd. and Global Vice President-Research & Development at Sanofi AB. Education includes doctorates from Stanford University and the University of Gothenburg.
Postes actifs de Jan Orwar
| Sociétés | Poste | Début |
|---|---|---|
| FLUICELL AB | Directeur/Membre du Conseil | 01/01/2015 |
Chalmers University of Technology
 Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 17/01/2011 |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Jan Orwar
| Sociétés | Poste | Fin |
|---|---|---|
Nanoxis AB
 Nanoxis AB Miscellaneous Commercial ServicesCommercial Services Provides tools and services for membrane protein research | Fondateur | 11/02/2014 |
| PIRML ENT | Directeur Technique/Scientifique/R&D | - |
Sanofi AB
 Sanofi AB Medical DistributorsDistribution Services Wholesales pharmaceutical products and medical equipment | Directeur Technique/Scientifique/R&D | - |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Directeur Général | - |
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Fondateur | - |
Formation de Jan Orwar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Piramal Enterprises Ltd.
 Piramal Enterprises Ltd. Investment ManagersFinance Provides asset management, loan and housing finance services and manufactures pharmaceuticals | Finance |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Gothenburg
 University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanoxis AB
Nanoxis AB Miscellaneous Commercial ServicesCommercial Services Provides tools and services for membrane protein research | Commercial Services |
Fluicell AB
 Fluicell AB BiotechnologyHealth Technology Provides fluid platforms for multi-functional pipettes for cell-based pharmacology research | Health Technology |
Sanofi AB
Sanofi AB Medical DistributorsDistribution Services Wholesales pharmaceutical products and medical equipment | Distribution Services |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
